Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT03245190 · COMPLETED
Trial details
- NCT number
- NCT03245190
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-28
- Primary completion
- 2019-11-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.